
Business · en
Shionogi to buy US-based IntraBio for $2bn to expand rare disease drug business
OSAKA/TOKYO -- Japanese drugmaker Shionogi will acquire U.S.-based biopharma company IntraBio for $2 billion, aiming to make treatments for rare disea

Business · en
OSAKA/TOKYO -- Japanese drugmaker Shionogi will acquire U.S.-based biopharma company IntraBio for $2 billion, aiming to make treatments for rare disea
Business · BBC News
Society · The Free Press
World · BBC News
Society · Global News
World · Blaze Media
World · CNA